You can narrow down the results using the filters
-
Meal timing, sleep & Health Outcomes in different Chronotypes (early birds/ intermediate/ night owls)
Expand descriptionThe current study will investigate the effect of meal time alteration on the quality of sleep, separately in early birds, night owls, and intermediate chronotypes. We hypothesize that taking the evening meal closer to bedtime reduces sleep quality in morning people, but not in night owls.
-
Development of a novel bile acid-based therapy to optimise postprandial glycaemic control in type 2 diabetes
Expand descriptionBile acids, released into the intestine after the meals, have long been regarded as simple ‘intestinal detergents’ to aid fat digestion. Recent evidence suggests that bile acids are also capable of regulating the blood sugar levels after meals, by releasing of a hormone from the intestines called glucagon-like peptide-1 (GLP-1). We recently showed that a bitter tasting substance, denatonium benzoate, could enhance the release of GLP-1. We now want to test whether combining a bile acid (taurocholic acid) with denatonium benzoate in capsules taken by mouth will improve blood glucose control after a meal in people with type 2 diabetes.
-
A pilot study on the efficacy of Mindfulness-Based Stress Reduction (MBSR) for improving mental health and metabolic profile among diabetes patients living in regional and rural north Queensland: A randomized clinical trial
Expand descriptionThis study aims to explore the efficacy of in-person and online MBSR for improving mental health and metabolic profile in diabetes patients living in regional and rural north Queensland using a RCT design. Our study will answer three research questions: 1) Is in-person MBSR efficacious for improving mental health and metabolic profile in diabetes patients? 2) Is online MBSR efficacious for improving mental health and metabolic profile in diabetes patients? 3) Are mental health benefits observed after 4- and 6-week interventions?
-
A Phase I, Randomised, Double Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of OXT-328 in Healthy Adult Volunteers
Expand descriptionThis is a first-in-human, single-centre, randomised, double blind, three-part single and multiple ascending dose study to assess the safety and tolerability of OXT-328 and how this drug acts in the body in healthy volunteers. Who is it for? You may be eligible for this study if you are aged 18 to 65 years and are in good general health without a clinically significant medical history. Study details: All healthy volunteer participants who choose to enrol in this study will be assigned by chance to receive either a single or multiple doses of OXT-328 or placebo. All participants will have their vital signs checked (heart rate, blood pressure, temperature, etc), and will provide blood and urine samples for testing. The data generated in this study will inform the design of future clinical studies and to select the dose(s) for future studies in patients with CIPN.
-
Effects of Rooibos Extract on Anxiety Levels
Expand descriptionThe REAL study is a pilot randomised, placebo-controlled clinical trial investigating the effects of green rooibos tea extract supplementation (dose = 500mg of rooibos extract) on anxiety levels in mildly to moderately anxious adults. The study incorporates a one week baseline period, 8-week intervention period and 2-week follow up.
-
Exercise, immunity and vaccination in chronic obstructive pulmonary disease (COPD)
Expand descriptionA sudden worsening of respiratory symptoms in Chronic obstructive Pulmonary Disease (COPD) is called a flare up. These flare ups are caused by respiratory infections. Exercise programs can reduce the number of people experiencing a flare up of COPD by as much as 40%. We don’t yet know why this happens. Key reasons why people with COPD have flare ups include weakened body defences (immune system) against respiratory infections. Measuring responses to safe, but foreign substances like vaccines provide one of the best ways to test how well the immune system defends against infections. We intend to find out if it is possible to use the flu or COVID-19 booster vaccines to understand how exercise changes the immune system of people with COPD. The project will recruit 45 volunteers with COPD. The project will split the volunteers into 3 groups: 1) 8 week exercise program before receiving a flu or COVID-19 vaccine; 2) 8 week exercise program before receiving a flu or COVID-19 vaccine and a single exercise session immediately after vaccination; 3) no exercise before or after flu or COVID-19 vaccine. We will collect blood and saliva from volunteers at the start of the project, before vaccination and on three occasions after vaccination.
-
Randomized Controlled Trial of Duration of Antibiotic Prophylaxis in Head and Neck Surgery with Free Flap Reconstruction, HEDAX Trial
Expand descriptionStudy Purpose: The purpose of this research is to establish whether 72 hours of antibiotics is superior to 24 hours of antibiotics in preventing infections of surgical wounds. Who is it for? You may be eligible for this study if you are an adult male or female Undergoing head and neck tumour resection and primary free flap reconstructive surgery for upper aerodigestive tract defects. Study details Participants will be randomly assigned to either 72-hour or 24-hour peri-operation antibiotic prophylaxis groups. Post head and neck operation and free flap reconstructive surgery, they will be monitored from postoperative day 1 to day 30 for incidence of surgical site infection using methods like culture, biochemical tests, radiological imaging, clinical diagnosis and Clavien-Dindo Classification of Surgical complications. It is hoped this information will improve perioperative management so that the best possible outcomes from surgery are achieved for patients having these major procedures.
-
Utility of smartwatches for investigation of the patient with palpitations
Expand descriptionThe purpose of the study is to assess the efficacy of smartwatches to investigate patients with palpitations. These are commonly worn by members of the general public, and because they are worn continuously may be able to capture an ECG at the time of palpitations. This may have a benefit over Holter monitors, as these are only worn for a 24-hour period - therefore if the palpitations occur outside the 24-hour monitoring period, patients will not receive a diagnosis.
-
Investigating Sodium Butyrate as Treatment for Anorexia Nervosa
Expand descriptionThe primary purpose of this study is to investigate the effects of sodium butyrate in the treatment of anorexia nervosa. We hypothesise that there will be a significant difference in a) improvement of ED symptoms from baseline to end of treatment, and b) increase in BMI from baseline to end of treatment.
-
Promoting haemostasis for central venous access devices: a randomised controlled trial
Expand descriptionWhen a central venous access device (CVAD – incorporates both centrally and peripherally inserted central catheters) is inserted, it breaches the body’s protective barrier – the skin. Together with the patient’s intrinsic risk factors associated with their illness (e.g., cancer and deranged metabolic function such as in critical illness), this places them at risk of persistent bleeding at the catheter exit site and systemic infections. These complications are highly correlated; bleeding at the insertion site causes dressing disruption, which is associated with an increased risk for central line-associated bloodstream infections (CLABSI). Potassium ferrate haemostatic discs and powder (StatSeal®, Biolife, Sarasota, Florida) contain a strong haemostatic agent which has primarily been used to promote haemostasis post-interventional vascular procedures and interventional cardiology. The haemostatic disc and powder also has the option of being applied at the CVAD skin exit site, however, its role to prevent haemostasis and promote dressing integrity (thereby reducing the risk of infection with longer-dwelling venous access devices), is yet to be explored. To provide further evidence and inform clinical practice, it is important to address this evidence-practice gap and test the safety and efficacy of the potassium ferrate products in promoting haemostasis and preventing dressing disruption for CVADs.